Carcinoembryonic antigen (CEA) is a broad-spectrum tumor marker, which plays an important role in the differential diagnosis, disease monitoring, and efficacy evaluation of malignant tumors (Cheong et al., 2020; Chi et al., 2020). This evidence concerns the gene CEACAM5 and cancer.